Ultragenyx Pharmaceutical, Inc. (RARE)
23.75
+0.04
(+0.17%)
USD |
NASDAQ |
May 22, 09:47
Ultragenyx Pharmaceutical Total Liabilities (Quarterly) : 1.525B for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 134.91M |
| BioMarin Pharmaceutical, Inc. | 2.379B |
| Regeneron Pharmaceuticals, Inc. | 9.445B |
| Xencor, Inc. | 221.21M |
| REGENXBIO, Inc. | 320.81M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.296B |
| Shareholders Equity (Quarterly) | -236.00M |
| Debt to Equity Ratio | -5.085 |
| Current Ratio | 2.022 |
| Net Debt Paydown Yield | -2.82% |